Mainz Biomed Secures up to $50M in New Funding
BERKELEY, Calif. and MAINZ, Germany, June 29, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company…
Browsing Tag
Biomed
Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in…
BERKELEY, Calif. and MAINZ, Germany, June 28, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company…
Mainz Biomed Expands into Romania Through Partnership with Bioclinica
ColoAlert® will be offered to an addressable market of 6 million patients through 15 laboratories. BERKELEY, Calif. and MAINZ, Germany, June 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV…
Mainz Biomed to Participate in Digestive Disease Week 2023
<!-- Name:DistributionId Value:1000807335 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of…
<!-- Name:DistributionId Value:1000802063 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for…
<!-- Name:DistributionId Value:1000796841 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal…
<!-- Name:DistributionId Value:1000783396 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of…
Enrollment remains on track to complete in Q1 2023 with results in 1H 2023Potential to identify advanced adenomas, a type of pre-cancerous polyp often attributed to colorectal cancer (CRC)…
Mainz Biomed Appoints Dr. Douglas Rex to its Medical Advisory Board
Distinguished Professor Emeritus of Medicine at Indiana University School of Medicine, Chancellor’s Professor at Indiana University Purdue University Indianapolis, and Director of Endoscopy…
Mainz Biomed et Dante Genomics annoncent la disponibilité commerciale totale de…
BERKELEY, Californie et MAINZ, Allemagne et NEW YORK, 19 août 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ : MYNZ) (« Mainz » ou la « Société »), une société de diagnostic en…